MedPath

Assessment of the Safety and Performance of a Lumbar Belt

Recruiting
Conditions
Low Back Pain
Interventions
Other: Control group LumbarBelt MID 500
Device: LumbarBelt SOFT 300
Device: LumbarBelt MID 500
Other: Control group LumbarBelt SOFT 300
Registration Number
NCT05552248
Lead Sponsor
Decathlon SE
Brief Summary

Decathlon has developed the Lumbar belt Soft 300 and Mid 500 products which are medical devices designed to reduce pain and improve function during sport practice for athletes with a common subacute or chronic low back pain.

The objective of this multicentre study is to collect data on the related clinical complications and clinical outcomes of market-approved Decathlon Lumbar belt range of products to demonstrate safety and performance of these devices in a real-world setting.

Outcome data collected from this study will provide the basis for Post-Market Surveillance (PMS) reporting, Clinical Study Report (CSR), Clinical Evaluation Report (CER) on Decathlon lumbar belt Soft 300/ Mid 500 devices and support peer-reviewed publications on products performance and safety.

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
60
Inclusion Criteria
  • Subject is aged ≥18 years old
  • Subject has a medically-confirmed common subacute or chronic low back pain
  • Subject performs regular physical activity
  • The current condition of his/her back allows the subject to pursue a usual physical activity
  • Subject has been informed and is willing to sign an informed consent form
  • Subject is willing to comply with protocol requirements and return to the study center for all clinical evaluations and required follow-up (12 weeks)
  • Subject is affiliated to the French social security regime
Exclusion Criteria
  • Subject has undergone a surgical treatment for his/her back
  • Subject presents associated neurologic signs (equina syndrome, radiculopathy, sciatica...)
  • Subject presents signs of specific low back pain (i.e. low back pain is a symptom of an underlying condition): presence of red flags
  • Subject has conditions that may interfere with his/her ability to understand protocol requirements, participate in scheduled visits, or provide his/her informed consent
  • Subject has worn a support (lumbar or sacroiliac hip belt) during sports sessions in the last month
  • Subject has any medical condition that could impact the study at investigator's discretion
  • Subject has a known hypersensitivity or allergy to the components of the devices (elastodiene, elastane, polyamide, polyethersulfone [PES])
  • Adult subject to a legal protection measure

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Control group 2Control group LumbarBelt MID 500Control group of the LumbarBelt Mid 500 group - no medical device used during sport practice (for 12 weeks)
Orthosis group 1LumbarBelt SOFT 300Use of LumbarBelt Soft 300 device during sport practice (for 12 weeks)
Orthosis group 2LumbarBelt MID 500Use of LumbarBelt Mid 500 device during sport practice (for 12 weeks)
Control group 1Control group LumbarBelt SOFT 300Control group of the LumbarBelt Soft 300 group - no medical device used during sport practice (for 12 weeks)
Primary Outcome Measures
NameTimeMethod
Functionnal scoreChange from Baseline functionnal score at 12 weeks

Comparison of the Oswestry Disability Index (10-item questionnaire with a global score from 0=best outcome to 100=worst outcome) between the baseline and last follow-up visit in each group (orthosis vs control), for each device model

Secondary Outcome Measures
NameTimeMethod
Safety (adverse events)12 weeks of follow-up

Comparison of adverse events rates between the groups (orthosis vs control), for each device model

Confidence level (confidence questionnaire related to physical activity)Change from Baseline confidence level at 12 weeks

Gap in the confidence level related to physical activity (scale from 0=worst outcome to 100=best outcome), between the baseline and last follow-up visit in each group (orthosis vs control), for each device model

Low back painChange from Baseline low back pain at 12 weeks

Comparison of low back pain, assessed through a Numerical Rating Scale (NRS) ranging from 0=best outcome to 10=worst outcome, between the groups (orthosis vs control), for each device model

Trial Locations

Locations (2)

Centre Hospitalier de Boulogne-sur-Mer

🇫🇷

Boulogne-sur-Mer, France

Centre de rééducation et de balnéothérapie Kinés Faches

🇫🇷

Faches-Thumesnil, France

© Copyright 2025. All Rights Reserved by MedPath